4X2T
X-ray crystal structure of the orally available aminopeptidase inhibitor, Tosedostat, bound to the M17 Leucyl Aminopeptidase from P. falciparum
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-12-15 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 1.12819 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 173.715, 176.698, 223.977 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 48.748 - 2.729 |
R-factor | 0.2225 |
Rwork | 0.220 |
R-free | 0.27370 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3kqx |
RMSD bond length | 0.008 |
RMSD bond angle | 1.290 |
Data scaling software | Aimless (0.1.29) |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine: 1.8.4_1496)) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 48.750 | 48.750 | 2.780 |
High resolution limit [Å] | 2.729 | 14.950 | 2.730 |
Rmerge | 0.052 | 0.465 | |
Rpim | 0.080 | 0.033 | 0.287 |
Total number of observations | 664861 | 4017 | 26638 |
Number of reflections | 181046 | ||
<I/σ(I)> | 7.7 | 13.1 | 2.5 |
Completeness [%] | 99.1 | 94.4 | 86.5 |
Redundancy | 3.7 | 3.5 | 3.4 |
CC(1/2) | 0.990 | 0.997 | 0.835 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8.6 | 298 | 35% (v/v) PEG 400, 0.1 M Tris pH 8.6, 0.2 M Li2SO4 |